Literature DB >> 11604592

Imaging modalities in central nervous system systemic lupus erythematosus.

T W Huizinga1, S C Steens, M A van Buchem.   

Abstract

Within the past few years, a clearly defined case definition system for central nervous system systemic lupus erythematosus (CNS-SLE) has been established. This has allowed cross-study comparisons of patients fulfilling the specific case definitions. New imaging techniques used on the subgroup of CNS-SLE patients that did not have any evidence for infarctions suggest that in these patients symptoms are associated with a diffuse process in the brain. Most likely this process leads to axonal damage and demyelination, ultimately leading to cerebral atrophy. With respect to the diagnostic work-up of SLE patients with neuropsychiatric symptoms, it has become clear that cranial magnetic resonance imaging is the technique of choice. Preliminary studies using quantitative magnetic resonance imaging techniques suggest that patients with neuropsychiatric symptoms caused by active CNS-SLE can be differentiated from patients with the same symptoms caused by residual disease.

Entities:  

Mesh:

Year:  2001        PMID: 11604592     DOI: 10.1097/00002281-200109000-00007

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  14 in total

1.  The effect of corticosteroid medication on quantitative MR parameters of the brain.

Authors:  Stefan C A Steens; Gerda M Steup-Beekman; Gerlof P Th Bosma; Faiza Admiraal-Behloul; Hans Olofsen; Joost Doornbos; Tom W J Huizinga; Mark A van Buchem
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

2.  Neurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institution.

Authors:  E Muscal; D R Bloom; J V Hunter; B L Myones
Journal:  Lupus       Date:  2009-12-21       Impact factor: 2.911

3.  Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice.

Authors:  Michelle M Sidor; Boris Sakic; Paul M Malinowski; David A Ballok; Curtis J Oleschuk; Joseph Macri
Journal:  J Neuroimmunol       Date:  2005-08       Impact factor: 3.478

4.  Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up.

Authors:  G Castellino; M Govoni; M Padovan; P Colamussi; M Borrelli; F Trotta
Journal:  Ann Rheum Dis       Date:  2005-01-07       Impact factor: 19.103

Review 5.  Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis.

Authors:  R H B Benedict; J L Shucard; R Zivadinov; D W Shucard
Journal:  Neuropsychol Rev       Date:  2008-06-03       Impact factor: 7.444

Review 6.  Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus.

Authors:  Simone Appenzeller; G Bruce Pike; Ann E Clarke
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

7.  Reproducibility of brain ADC histograms.

Authors:  Stefan C A Steens; Faiza Admiraal-Behloul; Jorrit A Schaap; Frank G C Hoogenraad; Claudia A M Wheeler-Kingshott; Saskia le Cessie; Paul S Tofts; Mark A van Buchem
Journal:  Eur Radiol       Date:  2003-11-14       Impact factor: 5.315

8.  Psychosis in patients with systemic lupus erythematosus.

Authors:  Raghavendra B Nayak; Govind S Bhogale; Nanasaheb M Patil; Sameeran S Chate
Journal:  Indian J Psychol Med       Date:  2012-01

9.  Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study.

Authors:  Yasuhiro Katsumata; Masayoshi Harigai; Yasushi Kawaguchi; Chikako Fukasawa; Makoto Soejima; Tokiko Kanno; Katsuji Nishimura; Takayuki Yamada; Hisashi Yamanaka; Masako Hara
Journal:  BMC Musculoskelet Disord       Date:  2010-01-23       Impact factor: 2.362

10.  Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus.

Authors:  Stefan C A Steens; Gerlof P T H Bosma; Gerda M Steup-Beekman; Saskia le Cessie; Tom W J Huizinga; Mark A van Buchem
Journal:  Arthritis Res Ther       Date:  2006-01-16       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.